Does Centene Ambetter Cover Zepbound? Medicare Advantage Coverage Guide 2026
Medicare Advantage enrollees with Ambetter Medicare (administered by Centene Corporation) frequently want to know whether their plan covers Zepbound (tirzepatide). The short answer is: coverage depends on specific formulary placement and clinical criteria.
Centene Ambetter’s Formulary Position on Zepbound
Ambetter Medicare uses a drug formulary that tiers medications based on coverage level. For the 2026 plan year, Zepbound is generally classified as Tier 5 (Non-preferred specialty) across Centene Ambetter plan designs.
What this means for you:
- Out-of-pocket cost: $100–$300+ based on your specific plan design
- Prior authorization: Mandatory — clinical documentation must be provided
- Quantity limits: Often enforced — limited to FDA-recommended dosing
- Step therapy: May require trying metformin, insulin, or other treatments first
In the donut hole phase, you’ll owe 25% coinsurance before catastrophic coverage applies.
Coverage for Different Indications
For chronic weight management (FDA-approved):
- Centene Ambetter typically will authorize Zepbound when prescribed for its FDA-approved indication
- PA criteria: HbA1c levels, prior medication history
- Approval rates are higher for the FDA-approved indication
For weight loss (where applicable):
- Traditional Medicare does not cover anti-obesity medications for weight loss alone
- However: 2025 policy changes expanded Part D coverage eligibility for GLP-1s prescribed for obesity
- Centene Ambetter may offer enhanced coverage that cover weight management medications — call Centene Corporation member services
How Much Does Zepbound Cost With Centene Ambetter
Estimating your out-of-pocket cost for Zepbound on Centene Ambetter involves your current coverage phase.
| Coverage Phase | Typical Cost |
|---|---|
| Initial Deductible ($545 in 2026) | You pay everything: $1,060–$1,200/month |
| Initial Coverage | 25-33% coinsurance |
| Coverage Gap (Donut Hole) | ~$250–$350/month |
| Catastrophic Coverage | 5% coinsurance or $4.50–$11.20 copay |
Starting in 2025, out-of-pocket Part D spending is capped at $2,000/year — a major benefit for GLP-1 users.
Tips for Getting Approved
- Request a formulary exception — If tier placement is too high, your doctor can request a lower tier classification with clinical justification
- Apply for patient assistance — Eli Lilly runs savings programs for eligible Medicare enrollees (note: savings cards typically don’t work with government plans)
- Compare plans during open enrollment — Open enrollment (Oct 15–Dec 7) is your chance to switch to a plan with better Zepbound coverage
- Check Low-Income Subsidy eligibility — Low-income beneficiaries can receive Extra Help (Low-Income Subsidy) that dramatically lower copays